EMMAC Life Sciences | European Medical Cannabis Company

Medical Cannabis

EMMAC is bringing together the latest science and research into the medical benefits of cannabis with pioneering cultivation, extraction and production to establish itself as the European leader in the production and supply of medical cannabis.

Research

EMMAC is at the forefront of the global medical cannabis industry working with research institutions to deliver clinical data regarding the efficacy of medical cannabis for pain and the potential public health benefits for patients.

CBD and Cannabinoids

EMMAC is capitalising on the rapidly growing CBD and cannabinoids market across Europe, leveraging its genetics and its technology and working on the benefits of CBD and other cannabinoids that are extracted from the cannabis plant.

Imperial College London & EMMAC Life Sciences

EMMAC announces pioneering research collaboration with Imperial College London

The partnership between EMMAC and Imperial College London has been forged to deliver a long-term comprehensive research programme designed to shape the future of the medical cannabis therapeutic industry.

View the press release

Find out more

EMMAC’s European Operations

EMMAC has developed unique supply and distribution partnerships across Europe to establish itself not only as a thought leader at the very forefront of research into the medical benefits of cannabis but also a European leader in the production and supply of medical cannabis, hemp and other derivative products.

Leadership Team

EMMAC Across Europe

EXPERIENCE & EXPERTISE

Leveraging decades of medical cannabis experience through a highly skilled board of advisors, management and consultants

Events & Press Releases

Upcoming Events

Cannabis Europa London

24th June, 2019

Cannabis Europa London builds on the momentum of the inaugural Cannabis Europa conference in May 2018. The event saw over

Press Releases

EMMAC presents to Scientific Committee (CSST) in Paris on Company’s advancement of scientific research into the therapeutic benefits of Medical Cannabis

16 May 2019, London. EMMAC Life Sciences Ltd, the European independent medical cannabis company, announces that on Wednesday 15th May, the Company presented to the French Scientific Committee (CSST),

EMMAC to import cannabis products into Germany; supply agreement with CC Pharma

14 May 2019, London. EMMAC Life Sciences Ltd, the European independent medical cannabis company, announces that it has entered the German medical cannabis market through the incorporation of About

Acquisition of Rokshaw, a leading UK Specials manufacturer

Immediate access to UK medical cannabis market 9 April 2019, London. EMMAC Life Sciences Ltd, the European independent medical cannabis company, is pleased to announce completion of the acquisition

EMMAC Life Sciences
Audley House, 12-12a Margaret Street, London, W1W 8RH
[email protected]

The European Independent Medical Cannabis Company